Invisalign (ALGN): Market Cap to Revenue

Symbol and logo of brand Invisalign (ALGN)

Align Technology, Inc. (ALGN) is a global leader in digital dentistry, advancing AI modeling and iTero scanners. Historical P/S dynamics demonstrate the market valuation of the business, where the value of 2.80 serves as the current metric. The brand maintains dominance in the aligner sector through a unified digital ecosystem. Process efficiency is supported by cloud services and the outsourcing of logistics tasks to external partners.

ALGN Invisalign P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Align Technology Inc (ALGN)

- share price and consensus valuation forecast:
General company analysis:ALGN aligntech.com
Core merchandise of Align Technology, Inc.

The specificity of Align Technology, Inc. (ALGN) lies in the creation of customized orthodontic systems, where high air logistics costs directly impact operational efficiency and final turnover. The ratio of market capitalization to annual revenue, reflected in the current price-to-sales value, allows for the determination of the business's overvaluation relative to actual sales, signaling a potential discount or the risk of a correction should market expectations shift.

Competitors of Align Technology, Inc.

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio GMED|TMDX (TransMedics Group, Inc.) - P/S Multiple|Alphatec Holdings (ATEC) - Price-to-Revenue Coefficient|P/S Multiple AORT|Market Cap to Revenue Enovis Inc. ENOV|P/S Multiple IART (Integra LifeSciences)|P/S Multiple establishmentlabs.com ESTA|BBNX - Price-to-Revenue Ratio|IRMD: Price-to-Revenue Ratio|EMBC (Embecta Inc.) - Market Cap to Revenue|Tandem Corp - Market Capitalization-to-Revenue Ratio|AXGN (AxoGen, Inc.) - P/S Multiple|Price to Sales si-bone.com SIBN|Price-to-Revenue Ratio Orthofix (OFIX)|Bioventus Inc (BVS) - Price-to-Revenue Multiple|OrthoPediatrics - Market Cap to Revenue|P/S Multiple Treace Corp TMCI|Strata Critical Medical Inc - P/S Multiple|Price-to-Revenue Coefficient carlsmed.com CARL|RxSight (RXST) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint Neuro)|Price-to-Revenue Ratio Stereotaxis Corp|Market Cap to Revenue Neuronetics, Inc (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio Anika Therapeutics, Inc. ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical, Inc. - Market Cap to Sales Volume|XTNT: P/S Multiple|n1mtc.com (NMTC) - P/S Multiple|Price-to-Revenue Ratio Modular Medical Inc|Price-to-Revenue Ratio MYO|P/S Multiple COCH|Price-to-Revenue Coefficient Vivos Therapeutics Inc|P/S Multiple NVNO (enVVeno Medical)|Price-to-Revenue Multiple Sintx Technologies Inc|TNON - Price-to-Revenue Ratio|LFWD (ReWalk Robotics) - Market Cap to Revenue Ratio|AMIX (autonomix.com) - Market Cap to Revenue|INVO Fertility Corp - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue BBLG|AXNX (axonics.com) - Market Cap to Sales Volume|P/S Multiple BIOL|DYNT - Price to Sales|P/S Multiple FNA (Paragon 28)|INVO - Market Cap to Revenue